Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Other Non Operating Income (2022 - 2026)

Kiniksa Pharmaceuticals International filings provide 5 years of Other Non Operating Income readings, the most recent being $3.4 million for Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 48.89% to $3.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $12.8 million, a 34.53% increase, with the full-year FY2025 number at $11.6 million, up 23.07% from a year prior.
  • Other Non Operating Income hit $3.4 million in Q1 2026 for Kiniksa Pharmaceuticals International, down from $3.5 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.5 million in Q4 2025 to a low of $34000.0 in Q1 2022.
  • Median Other Non Operating Income over the past 5 years was $2.3 million (2024), compared with a mean of $2.0 million.
  • Biggest five-year swings in Other Non Operating Income: soared 5288.24% in 2023 and later fell 2.07% in 2024.
  • Kiniksa Pharmaceuticals International's Other Non Operating Income stood at $794000.0 in 2022, then skyrocketed by 198.36% to $2.4 million in 2023, then decreased by 2.07% to $2.3 million in 2024, then soared by 50.91% to $3.5 million in 2025, then decreased by 2.49% to $3.4 million in 2026.
  • The last three reported values for Other Non Operating Income were $3.4 million (Q1 2026), $3.5 million (Q4 2025), and $3.1 million (Q3 2025) per Business Quant data.